Fig. 3From: Effect of sofosbuvir plus daclatasvir on virological response and liver function tests as a line of treatment for HCV related cirrhosis (a prospective cohort study)Change in total bilirubin during and post-treatment of the studied patients. P value < 0.001Back to article page